JP2017503760A5 - - Google Patents

Download PDF

Info

Publication number
JP2017503760A5
JP2017503760A5 JP2016534901A JP2016534901A JP2017503760A5 JP 2017503760 A5 JP2017503760 A5 JP 2017503760A5 JP 2016534901 A JP2016534901 A JP 2016534901A JP 2016534901 A JP2016534901 A JP 2016534901A JP 2017503760 A5 JP2017503760 A5 JP 2017503760A5
Authority
JP
Japan
Prior art keywords
alkyl
group
cycloalkyl
atoms
membered aromatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016534901A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017503760A (ja
JP6441928B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/075358 external-priority patent/WO2015078802A1/en
Publication of JP2017503760A publication Critical patent/JP2017503760A/ja
Publication of JP2017503760A5 publication Critical patent/JP2017503760A5/ja
Application granted granted Critical
Publication of JP6441928B2 publication Critical patent/JP6441928B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016534901A 2013-11-28 2014-11-24 新規インダニルオキシフェニルシクロプロパンカルボン酸 Expired - Fee Related JP6441928B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13194945.5 2013-11-28
EP13194945 2013-11-28
PCT/EP2014/075358 WO2015078802A1 (en) 2013-11-28 2014-11-24 New indanyloxyphenylcyclopropanecarboxylic acids

Publications (3)

Publication Number Publication Date
JP2017503760A JP2017503760A (ja) 2017-02-02
JP2017503760A5 true JP2017503760A5 (enExample) 2018-01-11
JP6441928B2 JP6441928B2 (ja) 2018-12-19

Family

ID=49726512

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016534901A Expired - Fee Related JP6441928B2 (ja) 2013-11-28 2014-11-24 新規インダニルオキシフェニルシクロプロパンカルボン酸

Country Status (4)

Country Link
US (1) US9308194B2 (enExample)
EP (1) EP3074375B1 (enExample)
JP (1) JP6441928B2 (enExample)
WO (1) WO2015078802A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018095877A1 (en) * 2016-11-28 2018-05-31 Boehringer Ingelheim International Gmbh Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
JP6968181B2 (ja) * 2017-01-26 2021-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インダニルアミノピラジニルシクロプロパンカルボン酸、その医薬組成物及び使用
WO2018146008A1 (en) * 2017-02-08 2018-08-16 Boehringer Ingelheim International Gmbh Indanylaminoazadihydrobenzofuranylacetic acids, pharmaceutical compositions for the treatment of diabetes
WO2019160882A1 (en) 2018-02-13 2019-08-22 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
WO2019204609A1 (en) 2018-04-19 2019-10-24 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
BR112020026746A2 (pt) 2018-07-13 2021-03-30 Gilead Sciences, Inc. Composto, composição farmacêutica, métodos para inibir pd-1, pd-l1 e/ou a interação de pd-1/pd-l1 e para tratar câncer, e, kit para tratar ou prevenir câncer ou uma doença ou condição.
CN112955435B (zh) 2018-10-24 2024-09-06 吉利德科学公司 Pd-1/pd-l1抑制剂
JP7135931B2 (ja) 2019-02-22 2022-09-13 スズキ株式会社 車両の走行制御装置
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ，インク． Ｇｐｒ１１９アゴニスト
PH12022552277A1 (en) 2020-02-28 2024-03-04 Kallyope Inc Gpr40 agonists
JP2023526625A (ja) 2020-05-19 2023-06-22 キャリーオペ，インク． Ａｍｐｋアクチベーター
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030701A1 (es) * 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
MX2010014571A (es) * 2008-06-25 2011-03-25 Daiichi Sankyo Co Ltd Compuestos de acido carboxilico.
HUE025363T2 (en) * 2010-12-01 2016-02-29 Boehringer Ingelheim Int Indanyl Oxide Hydrobenzofuranylacetic Acids that can be used to treat metabolic syndrome

Similar Documents

Publication Publication Date Title
JP2017503760A5 (enExample)
JP2012513416A5 (enExample)
JP2014525420A5 (enExample)
EA201700230A1 (ru) Определенные аминопиридины, композиции на их основе и способы их применения
JP2015511613A5 (enExample)
SI2738156T1 (en) TETRACYCLINE COMPOSITE SUBSTITUTED WITH 9-AMINOMETHYL
JP2016536363A5 (enExample)
JP2015531773A5 (enExample)
PE20190662A1 (es) Composiciones farmaceuticas que contienen derivados de piridona policiclicos sustituidos y profarmaco de los mismos
JP2010504286A5 (enExample)
JP2013507423A5 (enExample)
JP2014502988A5 (enExample)
JP2016536364A5 (enExample)
JP2013507434A5 (enExample)
JP2013531029A5 (enExample)
RU2015149009A (ru) 19-нор нейроактивные стероиды и способы их применения
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
JP2011137006A5 (enExample)
JP2010524932A5 (enExample)
JP2015504091A5 (enExample)
NZ739248A (en) Inhibitors of hepatitis c virus
AR060623A1 (es) Compuestos derivados de 2-azetidinona y un metodo de preparacion
RU2012125971A (ru) Новые химические соединения производные 2,4-диамино-1,3,5-триазина для профилактики и лечения заболеваний человека и животных
TN2019000170A1 (en) Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
MX2016016538A (es) Derivados de quinazolinona como inhibidores de fosfatidilinositol 3-cinasa.